Project description
Europe joins forces to tackle COVID-19
Convalescent plasma (CP) from recovered COVID-19 patients is being considered as a potential treatment. The EU-funded SUPPORT-E project aims to support high quality clinical evaluation of COVID-19 CP as well as data collection and analysis. It also strives to improve CP potency assessment, develop evidence-based recommendations on the appropriate use of CP for the treatment of COVID-19 across EU Member States and promote best practices regarding CP collection and use in the current health crisis as well as in subsequent crises involving novel pathogens. By bringing together major European blood establishments with world leading research capabilities, SUPPORT-E constitutes the first EU coordinated research effort to support high quality clinical and scientific evaluation of COVID-19 CP.
Fields of science
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
- medical and health sciencesbasic medicineimmunologyimmunotherapy
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantivirals
Programme(s)
Funding Scheme
RIA - Research and Innovation action
Coordinator
1066 CX Amsterdam
Netherlands
See on map
Participants (11)
93210 La Plaine Saint Denis
See on map
68167 Mannheim
See on map
1006 AN Amsterdam
See on map
1180 Bruxelles
See on map
8200 Aarhus
See on map
00161 Roma
See on map
27100 Pavia
See on map
46100 Mantova
See on map
WD24 4QN Watford
See on map
2300 Kobenhavn S
See on map
3001 Bern
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.